Yahoo Finance How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Neurocrine Biosciences is making good on its promise to diversify from Ingrezza. Meanwhile, the biotech stock is angling for a record.
Neurocrine Biosciences is making good on its promise to diversify from Ingrezza. Meanwhile, the biotech stock is angling for a record.
The first surgery could happen within eight years, it has been claimed
The Princess of Wales revealed on March 22 that she had been diagnosed with an unspecified kind of cancer.
Supplements of fish oil may raise the risk of stroke and a form of heart disease called atrial fibrillation, a new study revealed.
Alert issued to doctors to watch out for bacterial infection with high case fatality rate and meningitis symptoms
The IMF has urged ministers to raid inheritances and charge drivers for using the roads in a bid to find the cash to increase spending, even as drivers buy electric cars and, therefore, stop paying tax on petrol and diesel.
Cat Holden thought she had a muscle twinge but it was actually far more serious.
This FTSE 100 company has been in decline for several years, but Mark David Hartley reckons the stock could be set for a recovery. The post Down 51% in a year! I reckon this oversold FTSE 100 stock is now ripe for a comeback appeared first on The Motley Fool UK.
After demotion from the FTSE 100, this share fell off the radar for many investors. But it has a very high dividend and looks undervalued to me. The post A 9.5% yield but down 35%! This overlooked FTSE dividend superstar looks a bargain to me! appeared first on The Motley Fool UK.
This FTSE 100 stock has crashed by 71% over five years. Although it might look like a bargain, our writer explains why he's avoiding the company. The post Near a 52-week low, I wouldn’t touch this FTSE 100 stock with a bargepole! appeared first on The Motley Fool UK.
Former President Donald Trump on Tuesday said he was open to supporting regulations on contraception and that his campaign would release a policy on the issue “very shortly,” comments that he later said were misinterpreted. The comments, made during an interview with a Pittsburgh television station, suggested that a future Trump administration might consider imposing mandates or supporting state restrictions on such highly personal decisions as whether women can have access to birth control. “We’re looking at that and I’m going to have a policy on that very shortly,” Trump responded, according to a video of the interview that was briefly posted online before it was supposed to air, then taken down.
City Comment: The Bank should start chopping interest rates as soon as it can
A self-confessed "it girl" is having her entire shoulder removed and replaced with metal after doctors discovered an avocado-sized tumour in her left shoulder joint. Cat Holden, 23, went from working in London and going on holidays abroad, to living back with her parents and needing 24-hour care and says the diagnosis ruined her life. She experienced her first symptoms - a shoulder twinge and weak arms - a year before diagnosis, initially believing she'd injured herself at the gym. But after a round of physiotherapy and a misdiagnosis of tendonitis, Cat visited a private health clinic asking for an MRI. On January 10, 2024, doctors spotted an avocado-sized tumour in her left shoulder and, on March 8, she was told it was cancerous.
Jon Smith scratches his head over a dividend stock that has a very high yield, but appears to be that way for a particular reason. The post 18% per annum: is this dividend stock too good to turn down? appeared first on The Motley Fool UK.
Looking for the best-value passive income shares to buy? Here are a couple Royston Wild thinks look far too cheap at current prices. The post 2 cheap passive income shares to consider before it’s too late! appeared first on The Motley Fool UK.
Harvey Jones piled into this beaten down UK share because it looks cheap and offers a sky-high yield. Now he's having to be patient. The post I think this may be an unmissable chance to buy an oversold UK share before it rallies hard appeared first on The Motley Fool UK.
The error, worth more than the GDP of Denmark, was partially blocked by Citigroup, but almost $200 billion worth of shares were still sent to a trading algorithm
What could be more delightful than communing with nature in a glorious landscape, far from the crowds, luxuriating in the warmth and peace of summer? It is the perfect holiday scene. But unfortunately, there may be ticks about ready to spoil the fun, sensing your presence, easily latching onto clothing in an existential quest for their next meal.
Charles McQuillan/Getty ImagesDespite her cancer diagnosis, the Princess of Wales, Kate Middleton, has been doing a little work from home—but won’t be returning to public life anytime soon.Her office said Tuesday that she had remained heavily involved and “always on,” as a landmark new report for the Early Childhood Center, one of her key causes, was published. However, the office added that her involvement should not be seen as a signal she was about to return to her public role, citing her nee
Jon Smith takes note of a recent purchase from the famous investor behind The Big Short and explains his view on the BP share price. The post Is the BP share price set to soar after Michael Burry invests in the firm? appeared first on The Motley Fool UK.
The DWP faces an inquiry from the country's human rights watchdog, it was announced today.